Kenneth C. Cundy - 29 Feb 2024 Form 4/A Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Scientific Officer
Signature
/s/ Kenneth C. Cundy
Issuer symbol
ANEB
Transactions as of
29 Feb 2024
Net transactions value
$0
Form type
4/A
Filing time
08 Mar 2024, 08:07:25 UTC
Date Of Original Report
01 Mar 2024
Previous filing
13 Dec 2022
Next filing
07 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +72,613 $0.000000 72,613 29 Feb 2024 Common Stock 72,613 $2.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter beginning on April 1, 2024.

Remarks:

*This Form 4 is being filed to amend the exercise price of the stock option